Biotech companies often seek options for non-dilutive funding or exit opportunities to fund R&D and return value to investors. Pharma companies are constantly on the lookout for promising assets to enrich their pipelines, to remain top of their game in the face of looming patent cliffs. The panel will provide insight on the topics below from the perspectives of pharma, biotech and venture capital:
- How does a biotech company navigate vast pharma organisations to find the champion who would back their asset?
- What does a pharma company look for in an asset and how does it source them?
- Proven steps to build a mutually beneficial relationship.
The panel will be followed by drinks and networking with sweeping view of London from the 54th floor of 22 Bishopsgate.
Date: Wednesday, 5 March 2025
5:30 – 6:00 pm Registration
6:00 – 7:00 pm Panel Discussion
7:00 – 9:00 pm Networking Reception
Location: Covington & Burling LLP, 22 Bishopsgate, London EC2N 4BQ
